Alaunos Therapeutics reported $1.94M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Amgen USD 9.13B 316M Dec/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Biogen USD 3.86B 1.1B Sep/2025
Bioline Rx USD 7.91M 725K Sep/2025
Bristol-Myers Squibb USD 10.21B 5.52B Dec/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Corcept Therapeutics USD 125.14M 22.39M Sep/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
Incyte USD 2.93B 508.08M Sep/2025
Ionis Pharmaceuticals USD 2.24B 1.94B Sep/2025
J&J USD 18.23B 10.35B Sep/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Merck USD 18.17B 10.16B Sep/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Novartis USD 9.56B 2.9B Sep/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
PTC Therapeutics USD 672.62M 344.77M Sep/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
TG Therapeutics USD 178.32M 100.54M Sep/2025
Tilray USD 264.83M 43.16M Jun/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025